The free software community has always thwarted the toughest challenges facing freedom in technology. This winter season, we want to thank the many individuals and projects that have helped us get ...

If you’re obsessed with valuable MTG cards, check out for top ten most expensive cards launched into the TCG in 2025, the highest being over $30,000.

Former Google CEO Eric E Schmidt has warned that artificial intelligence capable of learning independently could emerge within four years. His remarks highlight why graduates must urgently build ...

Recursion Pharmaceuticals (RXRX) is drawing renewed attention after the appointment of Najat Khan as CEO and news of a narrowing net loss, both viewed as signals of improving execution. Investors also ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

RXRX Stock jumps after JPMorgan upgrade and trial data boost, fueling investor optimism in Recursion’s AI drug discovery ...

Recursion Pharmaceuticals' work could change the way that drugs are developed. Its pipeline features some exciting candidates, and it's partnering with major drugmakers. However, Recursion still needs ...

Najat Khan, PhD, unpacks realistic timelines for AI-based drugs to make clinical impact and her priorities for Recursion as incoming CEO.

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...